ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

NCI Director Defends Goal to Eliminate Suffering, Death From Cancer by 2015

June 13, 2003

Healy, Kessler Lose Jobs In Last-Minutes Maneuver By Bush White House To Defy Clinton Request

January 22, 1993

Komen Foundation Offer Fellowships

February 9, 1996